Exscientia to Present at Upcoming Investor Conferences in June

Rhea-AI Summary

Exscientia (Nasdaq: EXAI) has announced its participation in two significant investor conferences in June 2024. The management will be present at the Barclays Digital and Disruptive Technology Conference on June 11 at 9:45 a.m. BST in London, England. Additionally, they will engage in a fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference on June 11 at 3:20 p.m. EDT (8:20 p.m. BST) in Miami, Florida. Live webcasts of these events will be available on Exscientia's website under the 'Investors & Media' section. Archived replays will be accessible for about 30 days post-presentation.

Positive

• Exscientia's participation in two high-profile investor conferences may increase visibility and investor interest.
• Live webcasts and archived replays provide accessibility and transparency for shareholders and potential investors.

Negative

• No concrete data or metrics were provided regarding business performance or future projections.

OXFORD, England--(BUSINESS WIRE)-- Exscientia plc (Nasdaq: EXAI) today announced that members of Exscientia management will participate in the following upcoming investor conferences in June:

• Barclays Digital and Disruptive Technology Conference. Panel on Tuesday, June 11, 2024 at 9:45 a.m. BST in London, England
• Goldman Sachs 45^th Annual Global Healthcare Conference. Fireside chat on Tuesday, June 11, 2024 at 3:20 p.m. EDT (8:20 p.m. BST) in Miami, Florida

Live webcasts of the Barclays and Goldman Sachs events will be available on the Company’s website, under the “Investors & Media” section at www.investors.exscientia.ai. Archived replays of the webcasts will be available for approximately 30 days following the presentation.

About Exscientia

Exscientia is an AI-driven precision medicine company committed to discovering, designing and developing the best possible drugs in the fastest and most effective manner. Exscientia developed the first-ever functional precision oncology platform to successfully guide treatment selection and improve patient outcomes in a prospective interventional clinical study, as well as to progress AI-designed small molecules into the clinical setting. Our internal pipeline is focused on leveraging our precision medicine platform in oncology, while our partnered pipeline broadens our approach to other therapeutic areas. By pioneering a new approach to medicine creation, we believe the best ideas of science can rapidly become the best medicines for patients.

For more information visit us on www.exscientia.ai or follow us on LinkedIn @ex-scientia and X @exscientiaAI.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240530048166/en/

Investor Relations:

Sara Sherman / Chinedu Okeke

investors@exscientia.ai

Media:

Oliver Stohlmann

media@exscientia.ai

Source: Exscientia plc

FAQ

When is Exscientia presenting at the Barclays Digital and Disruptive Technology Conference?

Exscientia is presenting on June 11, 2024, at 9:45 a.m. BST.

What time is Exscientia's fireside chat at the Goldman Sachs 45th Annual Global Healthcare Conference?

The fireside chat is scheduled for June 11, 2024, at 3:20 p.m. EDT (8:20 p.m. BST).

How can I access the live webcasts of Exscientia's presentations?

Live webcasts will be available on Exscientia's website under the 'Investors & Media' section.

For how long will the archived replays of Exscientia's presentations be available?

Archived replays will be accessible for approximately 30 days following the presentations.